Total Funding
1
35
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
297478
Nu-Med Plus is a medical device company that develops a patented technology to safely deliver precision doses of nitric oxide.
Keith L Merrell: Chief Financial Officer- Jeffrey Robins: Owner, President/CEO
About the Company
Nu-Med Plus develops a patented technology to safely deliver precision doses of nitric oxide. A line of innovative systems is being developed to serve new patient populations. Delivered correctly, nitric oxide holds the potential to dilate constricted blood vessels in heart patients and heal respiratory complications in newborns. The company
scientists employ patented and patent-pending technology to also explore the potential of nitric oxide to treat wound care and those suffering from malaria, COPD, tuberculosis, and ARDS.
The company was established in 2011 and is based in Salt Lake City, Utah, United States.
